Left Ventricular Dysfunction

• FDA approval · 2024-09-19
  FDA Approved: ENALAPRIL MALEATE — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved the generic enalapril maleate from Rising Pharma Holdings under an Original Application (ANDA 218531).

• FDA approval · 2023-01-27
  FDA Approved: CAPTOPRIL — Original Application (AiPing Pharmaceutical, Inc.)

  The FDA approved AiPing Pharmaceutical’s Original Application for CAPTOPRIL (captopril), a generic ACE inhibitor. The approval supports indi…

• FDA approval · 2022-02-24
  FDA Approved: ENALAPRIL MALEATE ORAL SOLUTION — Original Application (NorthStar RxLLC)

  FDA approved NorthStar RxLLC's enalapril maleate oral solution as an original ANDA, enabling a generic version of enalapril maleate.

• FDA approval · 2021-10-27
  FDA Approved: VALSARTAN — Original Application (ScieGen Pharmaceuticals, INC.)

  FDA approves the original application for VALSARTAN (Valsartan) from ScieGen Pharmaceuticals as a generic angiotensin II receptor blocker. I…

• FDA approval · 2021-08-05
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved a supplemental application for enalaprilate maleate from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., effecti…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2020-04-14
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)

  FDA approved a supplemental application for Enalapril maleate from Northstar RxLLC under an ANDA.

• FDA approval · 2019-08-07
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

  FDA approves a supplemental application for enalapril maleate by Taro Pharmaceuticals U.S.A., Inc., pertaining to an approved product (gener…

• FDA approval · 2016-04-12
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for enalapril maleate from ScieGen Pharmaceuticals, Inc. (ANDA 075178).

• FDA approval · 2015-05-01
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for enalapril maleate from ScieGen Pharmaceuticals, indicating continued/expanded authorization …

• FDA approval · 2011-01-12
  FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for RAMIPRIL (ramipril) from Hikma Pharmaceuticals USA Inc., allowing a generic ramipril product to …

• FDA approval · 2008-04-23
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  The FDA approved a supplemental application for enalapril maleate (a generic ACE inhibitor) by Heritage Pharmaceuticals (d/b/a Avet Pharmace…

• FDA approval · 2007-11-13
  FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

  FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), approving an additional change to the approved ANDA…